{"id":52740,"date":"2025-11-22T19:00:30","date_gmt":"2025-11-22T19:00:30","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=52740"},"modified":"2025-12-05T21:13:37","modified_gmt":"2025-12-05T21:13:37","slug":"52740","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/52740","title":{"rendered":"Australian survey reports limited interest in CAB-LA PrEP by gay and bisexual men"},"content":{"rendered":"<p><strong>Simon Collins, HIV i-Base<\/strong><\/p>\n<p><strong>A recent cross-sectional Australian survey of gay and bisexual men reported a limited preference for CAB-LA. <\/strong><\/p>\n<p>Out of over 1680 responses the most preferred options were monthly oral pills (28%), followed by six-monthly injections (24%), removable implants (15%), daily oral (14%), event-driven oral (13%), and CAB-LA (4%). Importantly, none of the top three preferences are readily available and two are still only in research studies.<\/p>\n<p>This perhaps supports the decision by NICE in the UK to only fund limited access to CAB-LA for approximately 1000 people each year who are unable to take oral PrEP. [2]<\/p>\n<p>It might be a higher choice for other groups however, especially when people do not want to have pills at home.<\/p>\n<p>Reference<\/p>\n<ol>\n<li>Chan C et al. Assessing Demand for Long-Acting Injectable PrEP and Emerging PrEP Options for HIV Prevention in Australia: Results from a Cross-Sectional Survey of Men Who have Sex with Men. AIDS Behav (2025).<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s10461-025-04969-4\">https:\/\/doi.org\/10.1007\/s10461-025-04969-4<\/a><\/li>\n<li>HTB. NICE approves limited access to injectable cabotegravir PrEP in England and Wales + BHIVA notes on prescribing. (17 October 2025).<br \/>\n<a href=\"https:\/\/i-base.info\/htb\/52527\">https:\/\/i-base.info\/htb\/52527<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base A recent cross-sectional Australian survey of gay and bisexual men reported a limited preference for CAB-LA. Out of over 1680 responses the most preferred options were monthly oral pills (28%), followed by six-monthly injections (24%), removable &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[343,38,10],"tags":[],"class_list":["post-52740","post","type-post","status-publish","format-standard","hentry","category-journal-scan","category-treatment-access","category-transmission-and-prevention"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/52740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=52740"}],"version-history":[{"count":5,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/52740\/revisions"}],"predecessor-version":[{"id":52939,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/52740\/revisions\/52939"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=52740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=52740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=52740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}